Skip to main content

Table 5 Acute toxicity assessment (based on RTOG acute skin scoring)

From: A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects

  G0 G1 G2 G3 N0 of patients
Treatment end 34 (52%) 25 (39%) 6 (9%) 0 65
3 months 40 (62%) 19 (29%) 6 (9%) 0 65